BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20072885)

  • 1. Functional liposomal membranes for triggered release.
    Koçer A
    Methods Mol Biol; 2010; 605():243-55. PubMed ID: 20072885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying mechanosensitive ion channels using liposomes.
    Martinac B; Rohde PR; Battle AR; Petrov E; Pal P; Foo AF; Vásquez V; Huynh T; Kloda A
    Methods Mol Biol; 2010; 606():31-53. PubMed ID: 20013388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized purification and reconstitution method for the MscS channel: strategies for spectroscopical analysis.
    Vásquez V; Cortes DM; Furukawa H; Perozo E
    Biochemistry; 2007 Jun; 46(23):6766-73. PubMed ID: 17500538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and utilization of reversible and irreversible light-activated nanovalves derived from the channel protein MscL.
    Koçer A; Walko M; Feringa BL
    Nat Protoc; 2007; 2(6):1426-37. PubMed ID: 17545979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.
    Venugopalan P; Jain S; Sankar S; Singh P; Rawat A; Vyas SP
    Pharmazie; 2002 Oct; 57(10):659-71. PubMed ID: 12426945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A light-actuated nanovalve derived from a channel protein.
    Koçer A; Walko M; Meijberg W; Feringa BL
    Science; 2005 Jul; 309(5735):755-8. PubMed ID: 16051792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoliposomes for cancer therapy.
    Kontermann RE
    Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic nanoparticles for "smart liposomes".
    Nakayama Y; Mustapić M; Ebrahimian H; Wagner P; Kim JH; Hossain MS; Horvat J; Martinac B
    Eur Biophys J; 2015 Dec; 44(8):647-54. PubMed ID: 26184724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulating liposomes.
    Oku N; Namba Y
    Crit Rev Ther Drug Carrier Syst; 1994; 11(4):231-70. PubMed ID: 7664348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Bacillus thuringiensis (PS149B1) containing a Cry34Ab1/Cry35Ab1 binary toxin specific for the western corn rootworm Diabrotica virgifera virgifera LeConte forms ion channels in lipid membranes.
    Masson L; Schwab G; Mazza A; Brousseau R; Potvin L; Schwartz JL
    Biochemistry; 2004 Sep; 43(38):12349-57. PubMed ID: 15379574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-assisted triggered release of liposomal contents.
    Sarkar N; Banerjee J; Hanson AJ; Elegbede AI; Rosendahl T; Krueger AB; Banerjee AL; Tobwala S; Wang R; Lu X; Mallik S; Srivastava DK
    Bioconjug Chem; 2008 Jan; 19(1):57-64. PubMed ID: 18078309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational analysis of localized Ca2+-dynamics generated by heterogeneous release sites.
    Cooper Z; Greenwood M; Mazzag B
    Bull Math Biol; 2009 Oct; 71(7):1543-79. PubMed ID: 19440797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.